AusperBio Therapeutics develops therapeutics focused on hepatitis B treatment, aiming to advance clinical solutions for patients globally. The company is committed to bringing novel therapies to market, leveraging its scientific expertise.
Founded
2019
Total Funding
$100M+
Total Rounds
4
First Raise
Dec 27, 2024
Latest Raise
Aug 28, 2026
New funding rounds in your inbox every week 路 No noise, all Signal.
Founders and leadership hierarchy for this company.
| Date | Deal Type | Amount | Lead Investor |
|---|---|---|---|
| 8/28/2026 | |||
3 more funding rounds available
Upgrade to Premium to view all historical funding rounds
Upgrade to Premium to view Capital Momentum Score and performance metrics
New funding rounds in your inbox every week 路 Free